$MRNA

MRNA

Moderna Inc.

All takes and content in this window

As of 10-01
09-30
Schwab NetworkPublished 2026-09-30
“Wednesday's First Moves: MRNA Downgrade, BA Jet Contract, JBL Earnings”Citigroup
$MRNABearish
MRNA is a sell; Citi downgraded to Sell with $80 target (>60% downside) as the 200% rally on cancer trials is fully priced in and valuation assumes excessive future oncology success.

We view Moderna as a "sell" product. Citigroup gave it a "sell" rating today. This comes after Moderna's recent strong performance, thanks to some positive trial results . They have downgraded its rating to "Sell" from " Neutral".

At the same time, they raised the target price for the stock, but only to 80. This is a rise from 60. So, their outlook wasn't very positive before today. This means a potential drop of more than 60% from yesterday's closing levels.

09-29
Brian ShannonPublished 2026-09-29
“Brian Shannon on TraderTV Live 9/29/26”
$MRNANo side taken
MRNA momentum is unpredictable; a break above 190 could lead to a pullback toward 175 before further upside.

there is a question from one of our viewers. He asked what you think of mRNA and how this bull flag originated. Do you think there will be a continuation, or do you think the momentum will slowly fade?

I look at it and say that no one can predict where the momentum will fade. So instead, I look at it and say: look at the 30-minute timeframe, and it is innocent until proven guilty.

It moves along with this rising 5-day moving average. So I would say that you should look at the most recent relevant higher low above that 5-day moving average. So I think that if we break through the 190, the most likely scenario for mRNA is that it does something like this: maybe we start to divide, break through that lower bottom here, see a lower top, get stuck below the 5-day average, and then maybe pull back a bit towards the 175, and then it is ready to rise again.

Older record
Showing 2 / 2 on this page
See this ticker’s full history